Short Description
Quantifies alpha-L-fucosidase activity.
Development Stage
Research-Grade Protein & Enzyme Assay Development
Description
The ModifiSite™ α-L-Fucosidase Assay Kit quantifies enzyme activity as a biomarker for hepatocellular carcinoma and the lysosomal storage disorder fucosidosis. This assay supports diagnostic research and the monitoring of disease progression in oncology and genetics. By providing a quantitative measure of AFU activity, it aids in the validation of potential cancer biomarkers and enzyme replacement therapies.
Features
Quantitative determination in biological fluids; biomarker validation for hepatocellular carcinoma and genetic disorders.
Process Relevance
Oncology Biomarker Validation
Application Stage
Biomarker Validation
Applications
Diagnosis of fucosidosis and hepatocellular carcinoma marker.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 405 nm
Sample Type
Plasma, serum, tissue, cell lysate, samples
Research Areas
Oncology; Lysosomal Storage Disorders
Datasheet